PHARMACEUTICAL IP

  • Our Offering
    • Fractional in-house
    • Start-ups
    • Established pharma
    • International IP counsel
    • Investors
    • Due diligence
    • Evolve AI
  • Fractional in-house
  • Sectors
    • Pharmaceuticals
    • Biotechnology
    • Biologics
    • Cell & gene therapies
    • AI drug discovery
    • Chemistry
  • Evolve Insights
    • Articles
    • Webinars
    • Subscribe
  • About us
    • Our team
    • Join us
    • Contact us
  • Our Offering
    • Fractional in-house
    • Start-ups
    • Established pharma
    • International IP counsel
    • Investors
    • Due diligence
    • Evolve AI
  • Fractional in-house
  • Sectors
    • Pharmaceuticals
    • Biotechnology
    • Biologics
    • Cell & gene therapies
    • AI drug discovery
    • Chemistry
  • Evolve Insights
    • Articles
    • Webinars
    • Subscribe
  • About us
    • Our team
    • Join us
    • Contact us
  • Our offering
  • Fractional in-house
  • Sectors
  • Evolve Insights
  • Our team
  • Join us
  • Our offering
  • Fractional in-house
  • Sectors
  • Evolve Insights
  • Our team
  • Join us

Evolve Intellectual Property celebrates 4 years!

  • Sector: Patent law
  • 8th October 2025
 

Last month, Evolve celebrated its 4-year anniversary in style with a sparkling wine and canapés reception in Cambridge. Thank you to everyone who attended and for our clients’ continued trust and support. We look forward to many more years of helping our clients in their mission to deliver innovative medicines to market and bring hope to patients, and living our values of dedication, authenticity, collaboration and passion.

Evolve’s Founder Steven Gurney spoke at the event:

“Our ‘why’ has always been simple. To partner with pharmaceutical companies to deliver innovative medicines and bring hope to patients. It’s a privilege to be a small part of this vital sector. So tonight, while we celebrate Evolve, we also celebrate all of you working in or supporting life science, and doing your amazing work every day.”

The Evolve team (from the right): Iris Bell (IP Administrator), Claudia Greaves (Paralegal), Rose Hughes (Patent Attorney), Steven Gurney (Patent Attorney & Founder)

We were also once again delighted to be ranked in the Legal 500 and IP Stars. As a pharmaceutical IP specialist firm, we are proud to punch above our weight, reflecting the advantages of our agile approach and focus on pharma IP. We are proud to offer a comprehensive suite of IP services for the pharma industry built on our experience both in-house and private practice, including in-house fractional IP, due diligence and licensing deal support.

Related insights...

Launch of Evolve Webinars!

  • 25th June 2025
A series of live webinars on IP strategy for pharma & biotech professionals.

Evolve’s Steven Gurney recognised in IAM 1000 2025

  • 11th June 2025
We are delighted to announce that Evolve’s founder Steven Gurney has once again be recognised in the IAM patent 1000.

Event report: C5 Pharma & Biotech Patent Litigation in Europe (Day 1), Plausibility, UPC and antibody IP strategy

  • 27th May 2025
Navigating European pharma and biotech patent litigation is more complex than ever, with ongoing debates on plausibility, UPC intricacies, claim interpretation, and divergent strategies for antibody inventions.

Rose Hughes joins Evolve

  • 7th May 2025
Evolve Intellectual Property is pleased to welcome Dr. Rose Hughes as our new Patent Attorney.

Evolve joins the ranks of the Legal 500

  • 1st November 2024
We are delighted to announce that Evolve has joined the ranks of the Legal 500 Intellectual Property firms. The Legal 500 is one of the UK’s leading legal directories, known for its rigorous research methodology and independent analysis of the legal market. As a small boutique IP firm, we are particularly proud of this achievement. …
All Insights

evolve® is a trading entity of Evolve Intellectual Property Limited. Evolve Intellectual Property Limited is regulated by the Intellectual Property Regulation Board (IPReg). Details of the UK professional rules can be found on the IPReg website

registered address: 49 Greek Street, London, England, W1D 4EG

website out of house

© 2025 All Rights Reserved

Keep in touch

Subscribe

Contact Us